Exane Derivatives’s Oxford Square Capital OXSQ Stock Holding History

Exane Derivatives’s Portfolio OXSQ Stock Details OXSQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,733	Closed	-$62.3K	–	685
2019 Q2	$62.3K	Hold	9,733	–	–	0.01%	371
2019 Q1	$63.2K	Hold	9,733	–	–	0.01%	327
2018 Q4	$63K	Hold	9,733	–	–	0.01%	353
2018 Q3	$69.7K	Hold	9,733	–	–	0.01%	353
2018 Q2	$68K	Hold	9,733	–	–	0.01%	366
2018 Q1	$58.3K	Sell	9,733 -4,986	-34%	-$29.1K	0.01%	342
2017 Q4	$84.5K	Sell	14,719 -1,014	-6%	-$6.33K	0.01%	305
2017 Q3	$108K	Sell	15,733 -51	-0.3%	-$342	0.02%	246
2017 Q2	$100K	Buy	15,784 +1,547	+11%	+$11.1K	0.02%	270
2017 Q1	$105K	Buy	+14,237	New	+$103K	0.02%	227

Other funds holding OXSQ

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VEA

Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Exane Derivatives's OXSQ Position: Q3 2019 in Review

Exane Derivatives sold out of Oxford Square Capital (OXSQ) in Q3 2019, closing a stake of 9,733 shares — an estimated $62.3K sold.

Exane Derivatives first reported a position in OXSQ in Q1 2017 and held it in 10 quarters. The position peaked at $108K in Q3 2017. 66 funds tracked by Wall St. Rank hold OXSQ as of Q3 2019.

Exane Derivatives reported no remaining Oxford Square Capital position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 9,733 Oxford Square Capital shares in Q3 2019, an estimated $62.3K.
Exane Derivatives first reported a position in Oxford Square Capital in Q1 2017 and held it in 10 quarters.
Exane Derivatives's Oxford Square Capital position peaked at $108K in Q3 2017.
66 funds tracked by Wall St. Rank held Oxford Square Capital as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.